- Home
- CXAI vs UNCY Comparison
CXAI vs UNCY Comparison
Compare CXAI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- UNCY
- Stock Information
- Founded
- CXAI N/A
- UNCY 2016
- Country
- CXAI United States
- UNCY United States
- Employees
- CXAI N/A
- UNCY N/A
- Industry
- CXAI EDP Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- UNCY Health Care
- Exchange
- CXAI Nasdaq
- UNCY Nasdaq
- Market Cap
- CXAI 26.7M
- UNCY 31.9M
- IPO Year
- CXAI N/A
- UNCY 2021
- Fundamental
- Price
- CXAI $1.82
- UNCY $0.66
- Analyst Decision
- CXAI
- UNCY Strong Buy
- Analyst Count
- CXAI 0
- UNCY 4
- Target Price
- CXAI N/A
- UNCY $5.50
- AVG Volume (30 Days)
- CXAI 1.9M
- UNCY 1.5M
- Earning Date
- CXAI 11-12-2024
- UNCY 11-13-2024
- Dividend Yield
- CXAI N/A
- UNCY N/A
- EPS Growth
- CXAI N/A
- UNCY N/A
- EPS
- CXAI N/A
- UNCY N/A
- Revenue
- CXAI $7,200,000.00
- UNCY N/A
- Revenue This Year
- CXAI $3.86
- UNCY N/A
- Revenue Next Year
- CXAI $100.00
- UNCY N/A
- P/E Ratio
- CXAI N/A
- UNCY N/A
- Revenue Growth
- CXAI N/A
- UNCY N/A
- 52 Week Low
- CXAI $1.03
- UNCY $0.20
- 52 Week High
- CXAI $7.07
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- CXAI 54.43
- UNCY 52.04
- Support Level
- CXAI $1.66
- UNCY $0.62
- Resistance Level
- CXAI $1.96
- UNCY $0.87
- Average True Range (ATR)
- CXAI 0.25
- UNCY 0.08
- MACD
- CXAI 0.00
- UNCY -0.01
- Stochastic Oscillator
- CXAI 33.89
- UNCY 15.45
About CXAI CXApp Inc.
CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.